Assessment of the anti-diabetic activity of deoxyspergualin in low-dose streptozotocin-induced diabetic mice.
Nemoto
K
K
Research Laboratories, Pharmaceuticals Group, Nippon Kayaku Co., Ltd., Tokyo, Japan.
Sugawara
Y
Y
Takita
T
T
Nakamura
T
T
Takeuchi
T
T
D000818:Animals; D003524:Cyclosporins / Q000494:pharmacology; D003921:Diabetes Mellitus, Experimental / Q000517:prevention & control*; D004305:Dose-Response Relationship, Drug; D006146:Guanidines / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D051379:Mice; D008813:Mice, Inbred ICR
D003524:Cyclosporins; D006146:Guanidines; D007166:Immunosuppressive Agents; C037258:gusperimus